S3
(Promega)). The cells were lysed by passage through a 0.2 micron needle (approximately 15 times) and incubated on ice for 30 min. The soluble cell lystate was isolated by centrifuging at 15,000 rpm for 15 min and combined with the ANTI-FLAG agarose resin (Sigma-Aldrich) equilibrated with TBS buffer (50 mM Tri.HCl buffer, pH 7.4, containing 150 mM NaCl, 1 mM DTT, and 10 % glycerol) for 2 h. In order to remove nonspecifically bound proteins, the following wash steps were performed: overnight washed with 1 ml of TBS followed by several short washes (15 min) using a step gradient of NaCl (300 and 600 mM) in TBS buffer, pH 7.4 and finally washing with 1 ml of TBS buffer, pH 7.4, for 15 min. The FLAG-tagged human WT NOD2 protein was eluted from the resin by mixing with 1 ml of 0.05 mg/ml 3xFLAG peptide in Buffer A. The supernatant containing FLAG-tagged human WT NOD2 was collected by centrifugation at 5000 rpm for 30 s. On average (from a total of ten purifications), 1 mg of pure protein was obtained from one liter of culture. The purified protein was then aliquoted and stored at -80 °C. The protein concentration was determined by denaturing the protein with 6 M guanidine hydrochloride in lysis buffer, pH 7.4 and measuring the absorbance at 280 nm 3 .
The purity of the wild type protein was assessed by 4 -20 % polyacrylamide gels containing 0.1 % sodium dodecyl sulfate (supporting information Figure S1 ). 
Limited Proteolysis Experiment

NF-κΒ Activation Assay:
The assay was carried out using conditions described by Barnich et al, 2005 , J. Cell
Biol. 
Preparation of Gold Thiol Chips (Mixed SAM):
The gold chip (GE HealthCare) was immersed in a solution of a mixture of thiols (1% mole fraction of hexa(ethylene glycol)-carboxylic acid (EG) 6 CO 2 H)-terminated thiol in S7 tri(ethylene glycol) ((EG) 3 OH)-terminated thiol) (2 mM total concentration) for 12 h.
The chip was removed, rinsed with ethanol, and dried under a stream of nitrogen. The chip was then mounted onto a cassette following the protocol from the SIA Kit (GE Healthcare Lifesciences).
Buffers and Solutions:
Phosphate-buffered saline (PBS: 10mM phosphate, 138 mM NaCl, and 2.7 mM KCl) was prepared in distilled, deionized water. The solution was filtered and degassed.
Solutions of N-hydroxysuccinimide (NHS) (0.10 M) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (0.4 M) were prepared in distilled, deionized
water immediately before use. Muramyl dipeptide ligands 3 and 4 (20 mg mL -1 ) were dissolved in pH 8.0 25 mM phosphate buffer to a final concentration of (2 mg mL -1 ).
Ethanolamine was immobilized using a 1 M solutions of the compound at pH 8.5. SDS was prepared as a solution (10 mg mL -1 ) in PBS. Nod2 was dissolved in the appropriate buffer for the experimental conditions. In order to access a wide range of pHs a MES/HEPES buffer system was used (10 mM MES/HEPES pH 4.5 to 8.0, 20 mM NaCl, 5 mM MgCl 2 , 0.1% Triton X ). ATP and ADP were used at concentrations of 0.1 µM.
Surface Plasmon Resonance Spectroscopy:
The BIAcore 3000 instrument was used for all SPR studies described in this paper. The cassettes described above were docked into the BIAcore 3000.
Preparation and analysis of biotinylated MDP chips:
Biotinylated MDPs 7 and biotin were coupled to the Streptavidin sensor chips (SA sensor chips, GE Healthcare) according to the manufacturers protocol. Nod2 was prepared in the HEPES Buffer pH 7.0. We used a flow rate of 3 µL min -1 to inject Nod2 over the chip S8 for a total of ten minutes. The chip was washed with PBS for ten minutes, SDS for three minutes and PBS for ten minutes. Greater binding was observed in the sensorgrams for biotin vs the MDPs (supporting information Figure 2 ). Due to this artifact of the chip, we decided to move to direct immobilization of the MDPs. Figure 4 : Raw SPR data that was used to determine the binding constants: The sensorgrams were generated using the conditions described in the experimental section.
Biotin Sensorgram
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